ilomastat has been researched along with tranexamic acid in 2 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (tranexamic acid) | Trials (tranexamic acid) | Recent Studies (post-2010) (tranexamic acid) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 5,052 | 1,129 | 3,390 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Belzunce, M; Ma, H; Orbe, J; Oyarzabal, J; Páramo, JA; Rabal, O; Rodríguez, JA; Salicio, A; Sánchez-Arias, JA; Tan, H; Ugarte, A; Wu, W; Xu, M | 1 |
2 other study(ies) available for ilomastat and tranexamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.
Topics: Animals; Benzamides; Cell Membrane Permeability; Drug Design; Hemorrhage; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2015 |